Cochrane · systematic review · CD008876

Pharmacological treatment for memory disorder in multiple sclerosis

He, D, Zhang, Y, Dong, S, et al. · Cochrane Database of Systematic Reviews · 2013 · Cochrane Library

SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
7
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 7 · 100%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Donepezil for memory disorder in multiple sclerosis

Population: Patients with memory disorder in multiple sclerosis
7 questions
OutcomeEffectEvidenceStatus / GRADE
The mean change of total recall on the SRT from baseline Scale from: 0 to 72
no estimate extracted2 studies · 189 participantsModerate
Downgraded: imprecision
The mean change of total correct score on the 10/36 SRT from baseline Scale from: 0 to 40
no estimate extracted2 studies · 189 participantsModerate
Downgraded: imprecision
The mean change of total correct score on the SDMT from baseline Scale from: 0 to infinity
no estimate extracted2 studies · 189 participantsModerate
Downgraded: imprecision
The mean change of total correct score on the PASAT (2+3 sec) from baseline Scale from: 0 to 120
no estimate extracted2 studies · 189 participantsModerate
Downgraded: imprecision
The number of patients experiencing diarrhoea
RR 3.88 [1.66, 9.05]2 studies · 189 participantsModerate
Downgraded: imprecision
The number of patients experiencing nausea
RR 1.71 [0.93, 3.18]2 studies · 189 participantsModerate
Downgraded: imprecision
The number of patients experiencing abnormal dreams
RR 2.91 [1.38, 6.14]2 studies · 189 participantsModerate
Downgraded: imprecision